This information was published on 2026-03-22T00:11:37 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2596529 |
| (220) |
21 Oct 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience |
| (540) |
|
| (550) | Figurative |
| (730) |
Cerevel Therapeutics, LLC
|
| (750) |
Baker McKenzie
|
Find out more about publications on the About page.